GASTROINTESTINAL DILATION PROCEDURE

This adverse event was reported 47 times

These drugs are most commonly taken by patients reporting GASTROINTESTINAL DILATION PROCEDURE:

# Drug Count
0 ADALIMUMAB 19
1 VEDOLIZUMAB 9
2 PREDNISONE 8
3 RISANKIZUMAB-RZAA 7
4 USTEKINUMAB 6
5 MERCAPTOPURINE 5
6 ACETAMINOPHEN 4
7 INFLIXIMAB 4
8 METHOTREXATE 4
9 METHOTREXATE SODIUM 4
See all common drugs associated with GASTROINTESTINAL DILATION PROCEDURE

GASTROINTESTINAL DILATION PROCEDURE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NEOSTIGMINE METHYLSULFATE 3 0.0070
1 SODIUM ACETATE 1 0.0035
2 PURIXAN 1 0.0013
3 RASBURICASE 3 0.0012
4 CALCIUM CHLORIDE INJECTION 3 0.0010
5 ALBUMIN HUMAN 3 0.0006
6 PALONOSETRON HYDROCHLORIDE 3 0.0006
7 ALBUMIN (HUMAN) 3 0.0005
8 BECLOMETHASONE DIPROPIONATE 3 0.0005
9 CEFADROXIL 1 0.0005
See all drugs enriched for association with GASTROINTESTINAL DILATION PROCEDURE

GASTROINTESTINAL DILATION PROCEDURE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lipid-based Polyene Antifungal [EPC] 3 0.0002
1 Interleukin-23 Antagonist [EPC] 13 0.0001
2 Integrin Receptor Antagonist [EPC] 9 0.0001
3 Oxazolidinone Antibacterial [EPC] 3 0.0001
4 Penem Antibacterial [EPC] 3 0.0001
5 Polyene Antifungal [EPC] 3 0.0001
6 Insulin [EPC] 3 0.0001
7 Interleukin-12 Antagonist [EPC] 6 0.0001
8 Antidote [EPC] 3 0.0000
9 Glycopeptide Antibacterial [EPC] 3 0.0000
See all drug classes enriched for association with GASTROINTESTINAL DILATION PROCEDURE